Literature DB >> 25846741

Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).

Sarah C Tinker1, Suzan L Carmichael2, Marlene Anderka3, Marilyn L Browne4, Kristin M Caspers Conway5, Robert E Meyer6, Wendy N Nembhard7, Richard S Olney1, Jennita Reefhuis1.   

Abstract

BACKGROUND: The Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS) is a population-based, multi-Center case-control study of modifiable risk factors for selected birth defects in the United States. BD-STEPS is the second major research effort of the Centers for Birth Defects Research and Prevention, which extends and expands the initial research effort, the National Birth Defects Prevention Study (NBDPS).
METHODS: BD-STEPS focuses on 17 categories of structural birth defects selected based on severity, prevalence, consistent ascertainment, and previous findings that warrant additional research. Cases are identified through existing birth defects surveillance programs; controls are from vital records or birth hospital logs from the same catchment area. BD-STEPS uses a standardized computer-assisted telephone interview to collect information from case and control mothers on topics including demographics, health conditions, and medication use. Following the maternal interview, selected Centers request permission to sample residual newborn screening blood spots from state repositories for genetic analyses. New components planned for BD-STEPS include linkages with external datasets and use of online questionnaires to collect in-depth information on selected exposures.
RESULTS: BD-STEPS extends NBDPS by continuing to collect data on many exposures that were assessed in NBDPS, allowing data from both studies to be combined and providing an unprecedented sample size to analyze rare exposures. BD-STEPS expands upon NBDPS by collecting more detailed information on existing exposures as well as new exposures.
CONCLUSION: The goal of BD-STEPS is to provide women and healthcare providers with information they need to make decisions to promote the healthiest pregnancy possible.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  birth defects; case-control; congenital anomalies; epidemiology; pregnancy

Mesh:

Year:  2015        PMID: 25846741      PMCID: PMC4537667          DOI: 10.1002/bdra.23373

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  34 in total

1.  Use of over-the-counter medications during pregnancy.

Authors:  Martha M Werler; Allen A Mitchell; Sonia Hernandez-Diaz; Margaret A Honein
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 2.  Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples.

Authors:  Genoveva C E Keustermans; Sanne B E Hoeks; Jenny M Meerding; Berent J Prakken; Wilco de Jager
Journal:  Methods       Date:  2013-04-19       Impact factor: 3.608

3.  Self-reported maternal smoking during pregnancy by source in Utah, 2003-2007.

Authors:  Sivithee Srisukhumbowornchai; Sergey Krikov; Marcia L Feldkamp
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-07-23

Review 4.  Cancer and pregnancy: an overview for obstetricians and gynecologists.

Authors:  Ritu Salani; Caroline C Billingsley; Sarah M Crafton
Journal:  Am J Obstet Gynecol       Date:  2013-12-04       Impact factor: 8.661

Review 5.  Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature.

Authors:  Marlene T Anderka; Angela E Lin; Dianne N Abuelo; Allen A Mitchell; Sonja A Rasmussen
Journal:  Am J Med Genet A       Date:  2009-06       Impact factor: 2.802

6.  Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.

Authors:  Kara N D Polen; Sonja A Rasmussen; Tiffany Riehle-Colarusso; Jennita Reefhuis
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-12-26

Review 7.  The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.

Authors:  Michael A Rogawski; Wolfgang Löscher
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

8.  Validating assisted reproductive technology self-report.

Authors:  Rebecca F Liberman; Judy E Stern; Barbara Luke; Jennita Reefhuis; Marlene Anderka
Journal:  Epidemiology       Date:  2014-09       Impact factor: 4.822

9.  Prenatal nitrate intake from drinking water and selected birth defects in offspring of participants in the national birth defects prevention study.

Authors:  Jean D Brender; Peter J Weyer; Paul A Romitti; Binayak P Mohanty; Mayura U Shinde; Ann M Vuong; Joseph R Sharkey; Dipankar Dwivedi; Scott A Horel; Jiji Kantamneni; John C Huber; Qi Zheng; Martha M Werler; Katherine E Kelley; John S Griesenbeck; F Benjamin Zhan; Peter H Langlois; Lucina Suarez; Mark A Canfield
Journal:  Environ Health Perspect       Date:  2013-06-14       Impact factor: 9.031

10.  Maternal exposure to criteria air pollutants and congenital heart defects in offspring: results from the national birth defects prevention study.

Authors:  Jeanette A Stingone; Thomas J Luben; Julie L Daniels; Montserrat Fuentes; David B Richardson; Arthur S Aylsworth; Amy H Herring; Marlene Anderka; Lorenzo Botto; Adolfo Correa; Suzanne M Gilboa; Peter H Langlois; Bridget Mosley; Gary M Shaw; Csaba Siffel; Andrew F Olshan
Journal:  Environ Health Perspect       Date:  2014-04-11       Impact factor: 9.031

View more
  9 in total

1.  Editorial perspectives from the founding CDC leadership of the National Birth Defects Prevention study.

Authors:  Cynthia A Moore; Paula W Yoon; Larry D Edmonds; J David Erickson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-10

2.  The role of parental and perinatal characteristics on Langerhans cell histiocytosis: characterizing increased risk among Hispanics.

Authors:  Erin C Peckham-Gregory; Kenneth L McClain; Carl E Allen; Michael E Scheurer; Philip J Lupo
Journal:  Ann Epidemiol       Date:  2018-04-17       Impact factor: 3.797

3.  Editorial utility of population-based birth defects surveillance for monitoring the health of infants and as a foundation for etiologic research.

Authors:  Cynthia A Moore; Edward R B McCabe
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-10-12

4.  Testing and Validating Semi-automated Approaches to the Occupational Exposure Assessment of Polycyclic Aromatic Hydrocarbons.

Authors:  Albeliz Santiago-Colón; Carissa M Rocheleau; Stephen Bertke; Annette Christianson; Devon T Collins; Emma Trester-Wilson; Wayne Sanderson; Martha A Waters; Jennita Reefhuis
Journal:  Ann Work Expo Health       Date:  2021-07-03       Impact factor: 2.179

5.  The safety of asthma medications during pregnancy and lactation: Clinical management and research priorities.

Authors:  Christina D Chambers; Jerry A Krishnan; Lorene Alba; Jessica D Albano; Allison S Bryant; Melanie Carver; Lee S Cohen; Elena Gorodetsky; Sonia Hernandez-Diaz; Margaret A Honein; Bridgette L Jones; Richard K Murray; Jennifer A Namazy; Leyla Sahin; Catherine Y Spong; Kaveeta P Vasisht; Kevin Watt; Keele E Wurst; Lynne Yao; Michael Schatz
Journal:  J Allergy Clin Immunol       Date:  2021-03-10       Impact factor: 14.290

Review 6.  COVID-19 in pregnancy-what study designs can we use to assess the risk of congenital anomalies in relation to COVID-19 disease, treatment and vaccination?

Authors:  Helen Dolk; Christine Damase-Michel; Joan K Morris; Maria Loane
Journal:  Paediatr Perinat Epidemiol       Date:  2022-03-02       Impact factor: 3.103

7.  Medication use during pregnancy and birth defects in Hunan province, China, during 2016-2019: A cross-sectional study.

Authors:  Wei Zou; Shuting Xie; Changbiao Liang; Donghua Xie; Junqun Fang; Bo Ouyang; Li Sun; Hua Wang
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

8.  Correlates of knowledge of genetic diseases and congenital anomalies among pregnant women attending antenatal clinics in Lagos, South-West Nigeria.

Authors:  Chibuzor Franklin Ogamba; Alero Ann Roberts; Ochuwa Adiketu Babah; Chibuikem Anthony Ikwuegbuenyi; Oluwaseun Joseph Ologunja; Oluyinka Kehinde Amodeni
Journal:  Pan Afr Med J       Date:  2021-03-28

9.  The Baby Hearts Study - a case-control methodology with data linkage to evaluate risk and protective factors for congenital heart disease.

Authors:  N McCullough; H Dolk; M Loane; B M Lagan; F Casey; B Craig
Journal:  Int J Popul Data Sci       Date:  2019-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.